The transmembrane G protein-coupled receptor GPR44 (also known as CRTH2 or PTGDR2) that binds to endogenous Prostaglandin D2 has recently been identified as a suitable biomarker candidate for monitoring BCM through proteomic and transcriptomic screenings [8]. Here, PTGDR2 is linked to blue cone monochromacy.